Stock Analysis

Exploring 3 Undervalued Small Caps In Global With Insider Action

As global markets navigate the anticipation of interest rate decisions and mixed economic signals, small-cap stocks have shown resilience, with the Russell 2000 Index rising by 0.84% in early December. Amid these conditions, investors often seek opportunities in small-cap companies that demonstrate potential for growth and stability despite broader market uncertainties. Identifying such stocks involves looking at factors like strong fundamentals, market position, and insider activity that might indicate confidence from those closest to the company’s operations.

Advertisement

Top 10 Undervalued Small Caps With Insider Buying Globally

NamePEPSDiscount to Fair ValueValue Rating
Security Bank4.3x0.9x28.90%★★★★★★
Senior24.2x0.8x28.79%★★★★★☆
Centurion3.6x3.0x-53.25%★★★★☆☆
PSC9.7x0.4x21.09%★★★★☆☆
Chinasoft International21.7x0.7x-1199.38%★★★★☆☆
Hung Hing Printing GroupNA0.4x44.53%★★★★☆☆
Gooch & Housego45.2x1.1x24.15%★★★☆☆☆
Kendrion28.6x0.7x42.79%★★★☆☆☆
Ever Sunshine Services Group6.1x0.4x-399.00%★★★☆☆☆
CVS Group45.9x1.3x26.44%★★★☆☆☆

Click here to see the full list of 135 stocks from our Undervalued Global Small Caps With Insider Buying screener.

Let's uncover some gems from our specialized screener.

Civmec (ASX:CVL)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Civmec is an integrated, multi-disciplinary construction and engineering services provider with a focus on the energy, resources, infrastructure, marine, and defence sectors, boasting a market cap of A$0.58 billion.

Operations: The company's revenue streams are primarily derived from Resources, followed by Infrastructure, Marine & Defence, and Energy. The gross profit margin has shown variability over time, reaching 13.14% in the most recent period. Operating expenses have generally fluctuated around A$30 million with notable non-operating expenses impacting net income margins.

PE: 16.7x

Civmec, a company with potential for growth, has caught attention in the small-cap space. Despite relying entirely on external borrowing, which presents higher risk compared to customer deposits, their forecasted earnings growth of 13.97% annually suggests a promising trajectory. Insider confidence is evident as key figures have been purchasing shares throughout 2025. Recent discussions at the Annual General Meeting in September also indicate active engagement with stakeholders about future strategies and financial health.

ASX:CVL Share price vs Value as at Dec 2025
ASX:CVL Share price vs Value as at Dec 2025

BioGaia (OM:BIOG B)

Simply Wall St Value Rating: ★★★★☆☆

Overview: BioGaia is a Swedish company specializing in the development and sale of probiotic products for pediatric and adult health, with a market cap of approximately SEK 10.65 billion.

Operations: BioGaia generates revenue primarily from its Pediatrics and Adult Health segments, with the Pediatrics segment being the larger contributor. The company's cost structure includes significant expenses in sales and marketing as well as research and development. Over recent periods, BioGaia's gross profit margin has shown some variation, reaching 73.84% in Q2 2024 before slightly decreasing to 72.45% by Q4 2024.

PE: 31.4x

BioGaia, a company with a small market presence, is gaining traction through innovative probiotic solutions like their Prodentis FRESH BREATH lozenges. Recent earnings for Q3 2025 showed sales of SEK 326.64 million and net income of SEK 65.88 million, both improved from the previous year. The company's research on serotonin-producing bacteria highlights its focus on gut-brain health connections, potentially boosting future growth prospects despite reliance on external funding sources.

OM:BIOG B Share price vs Value as at Dec 2025
OM:BIOG B Share price vs Value as at Dec 2025

Vitec Software Group (OM:VIT B)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Vitec Software Group specializes in developing and delivering software solutions primarily for niche markets, with a focus on the software and programming sector, and has a market capitalization of approximately SEK 15.93 billion.

Operations: The company generates revenue primarily from its Software & Programming segment, reporting a revenue of SEK 3.58 billion for the latest period. It has experienced fluctuations in its gross profit margin, reaching 47.66% most recently. Operating expenses have been significant, with general and administrative expenses accounting for SEK 405.88 million in the latest quarter.

PE: 30.7x

Vitec Software Group, operating in a competitive industry, recently reported third-quarter sales of SEK 773.22 million, up from SEK 717.76 million the previous year. Despite this growth, net income slightly decreased to SEK 112.15 million from SEK 108.42 million. Notably, insider confidence is evident as Independent Director Jan Friedman purchased 1,000 shares for approximately SEK 314,800 in September 2025. The company's earnings are projected to grow at an annual rate of nearly 19%, though it relies heavily on external borrowing for funding which poses higher risk compared to customer deposits.

OM:VIT B Share price vs Value as at Dec 2025
OM:VIT B Share price vs Value as at Dec 2025

Seize The Opportunity

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if BioGaia might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About OM:BIOG B

BioGaia

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Flawless balance sheet with high growth potential and pays a dividend.

Similar Companies

Advertisement

Weekly Picks

WO
MGPI logo
woodworthfund on MGP Ingredients ·

THE KINGDOM OF BROWN GOODS: WHY MGPI IS BEING CRUSHED BY INVENTORY & PRIMED FOR RESURRECTION

Fair Value:US$4034.1% undervalued
17 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
DO
Double_Bubbler
EVTL logo
Double_Bubbler on Vertical Aerospace ·

Why Vertical Aerospace (NYSE: EVTL) is Worth Possibly Over 13x its Current Price

Fair Value:US$6090.0% undervalued
21 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
TI
TickerTickle
ORCL logo
TickerTickle on Oracle ·

The Quiet Giant That Became AI’s Power Grid

Fair Value:US$389.8142.8% undervalued
35 users have followed this narrative
3 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

RO
Robbo
PG logo
Robbo on Procter & Gamble ·

Insiders Sell, Investors Watch: What’s Going On at PG?

Fair Value:US$1506.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CW
VRNO logo
Cwburton on Verano Holdings ·

Waiting for the Inevitable

Fair Value:CA$5.5278.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
MarkoVT
5032 logo
MarkoVT on ANYCOLOR ·

Near zero debt, Japan centric focus provides future growth

Fair Value:JP¥7.11k32.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
119 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3926.6% undervalued
963 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8688.6% undervalued
77 users have followed this narrative
8 users have commented on this narrative
21 users have liked this narrative